PYPD (PolyPid) EV-to-OCF: (As of Jul. 31, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PYPD PolyPid Ltd PYPD
33 GF Score
Price $4.29
View Full Analysis

What is PolyPid EV-to-OCF?

EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, PolyPid's Enterprise Value is $73.69 Mil. PolyPid's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was $0.00 Mil. Therefore, PolyPid's EV-to-OCF for today is .

The historical rank and industry rank for PolyPid's EV-to-OCF or its related term are showing as below:

PYPD' s EV-to-OCF Range Over the Past 10 Years
Min: -2.73   Med: 0   Max: -2.57
Current: -2.64

During the past 12 years, the highest EV-to-OCF of PolyPid was -2.57. The lowest was -2.73. And the median was .

PYPD's EV-to-OCF is ranked worse than
53.05% of 1410 companies
in the Biotechnology industry
Industry Median: -3.345 vs PYPD: -2.64

EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2026-07-31), PolyPid's stock price is $4.29. PolyPid's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $-1.910. Therefore, PolyPid's PE Ratio (TTM) for today is At Loss.

PolyPid  (NAS:PYPD) EV-to-OCF Explanation

EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

PolyPid's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=4.29/-1.910
=At Loss

PolyPid's share price for today is $4.29.
PolyPid's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.910.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.

PolyPid EV-to-OCF Related Terms

PolyPid EV-to-OCF Historical Data

* Premium members only.

The historical data trend for PolyPid's EV-to-OCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PolyPid EV-to-OCF Chart

PolyPid Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EV-to-OCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.33 -0.44 -0.74 -1.14 -2.47

PolyPid Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EV-to-OCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 -2.47 0.00

PYPD vs GANX, MAIA, ACET: EV-to-OCF Comparison

For the Biotechnology subindustry, PolyPid's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PolyPid EV-to-OCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PolyPid's EV-to-OCF distribution charts can be found below:

* The bar in red indicates where PolyPid's EV-to-OCF falls into.


PYPD
33GF Score
PolyPid Ltd PYPD
EV-to-OCF is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PolyPid EV-to-OCF Calculation

PolyPid's EV-to-OCF for today is calculated as:

EV-to-OCF=Enterprise Value (Today)/Cash Flow from Operations (TTM)
=73.693/0
=

PolyPid's current Enterprise Value is $73.69 Mil.
PolyPid's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PolyPid Business Description

Other Exchanges 2PV:Germany
Address 18 Hasivim Street, Petach Tikva, ISR, 495376
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. The company's product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
33GF Score

Get the complete analysis for PYPD

EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.29
Price